Compare CADL & NCMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CADL | NCMI |
|---|---|---|
| Founded | 1999 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Advertising |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 357.4M | 306.0M |
| IPO Year | 2021 | 2006 |
| Metric | CADL | NCMI |
|---|---|---|
| Price | $6.20 | $3.58 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 4 |
| Target Price | ★ $19.00 | $5.63 |
| AVG Volume (30 Days) | ★ 1.7M | 467.0K |
| Earning Date | 05-14-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 3.38% |
| EPS Growth | ★ 58.62 | 52.17 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $125,000.00 | N/A |
| Revenue This Year | N/A | $11.20 |
| Revenue Next Year | N/A | $6.22 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.34 | $2.92 |
| 52 Week High | $7.66 | $5.92 |
| Indicator | CADL | NCMI |
|---|---|---|
| Relative Strength Index (RSI) | 56.36 | 60.85 |
| Support Level | $5.42 | $3.17 |
| Resistance Level | $6.41 | $3.77 |
| Average True Range (ATR) | 0.48 | 0.14 |
| MACD | 0.09 | 0.02 |
| Stochastic Oscillator | 49.22 | 72.83 |
Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
National CineMedia Inc is a cinema advertising platform in the U.S. It derives revenue from the sale of advertising to national, regional and local businesses through The Noovie Show and the CineLife Show, the cinema advertising and entertainment show seen on movie screens across the U.S., on LEN, a series of strategically-placed screens located in movie theater lobbies, as well as other forms of advertising and promotions in theater lobbies.